Valion Bio Inc (VBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 146 | 86 | 0 |
| Cost of Goods | N/A | N/A | 291 | 32 | N/A |
| Gross Profit | N/A | N/A | -145 | 54 | N/A |
| Operating Expenses | 5,634 | 1,872 | 2,629 | 2,020 | 1,377 |
| Operating Income | -5,634 | -2,104 | -2,483 | -1,934 | -1,377 |
| Interest Expense | 648 | 150 | -4 | 0 | 0 |
| Other Income | 57 | 161 | -117 | 3 | 4 |
| Pre-tax Income | -6,225 | -2,093 | -2,596 | -1,931 | -1,373 |
| Net Income Continuous | -6,225 | -2,093 | -2,596 | -1,931 | -1,373 |
| Net Income Discontinuous | 23 | -756 | N/A | N/A | -129 |
| Net Income | $-6,202 | $-2,849 | $-2,596 | $-1,931 | $-1,502 |
| EPS Basic Total Ops | -2.23 | -1.16 | -1.97 | -2.19 | -2.52 |
| EPS Basic Continuous Ops | -2.16 | -0.35 | -1.97 | -2.19 | -2.41 |
| EPS Basic Discontinuous Ops | 0.01 | -0.54 | N/A | N/A | -0.23 |
| EPS Diluted Total Ops | -2.23 | -1.16 | -1.97 | -2.19 | -2.52 |
| EPS Diluted Continuous Ops | -2.16 | -0.35 | -1.97 | -2.19 | -2.41 |
| EPS Diluted Discontinuous Ops | 0.01 | -0.54 | N/A | N/A | -0.23 |
| EPS Diluted Before Non-Recurring Items | -2.23 | N/A | -1.97 | -2.19 | -2.52 |
| EBITDA(a) | $-5,008 | $-1,772 | $-2,483 | $-1,933 | $-1,376 |